Observational study on the management of castration-resistant prostate cancer with unknown metastatic status in clinical practice. APHRODITE
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: JANSSEN-CILAG, SA
- Execution start: 23/12/2019
- End of execution: 30/04/2021
- IP: MIGUEL ARRABAL MARTIN